Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FJRWC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,111
Award facts
- Contract value 100% obligated
- $2,111.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,111.28 to DMS Pharmaceutical Group Inc. for 60 tablets of Eliquis 5 mg on October 27, 2025, with completion expected by October 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with no set-aside designation, indicating the award was made through unrestricted competition. The delivery location is Park Ridge, Illinois, and the order represents a routine pharmaceutical supply requirement for Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors. The PPV-G GEN V contract, awarded in November 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three optional renewal periods. This framework authorizes DLA to issue delivery orders for comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables, to support military healthcare facilities globally. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability as a critical supplier within the federal military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FJRWC?
SPE2DB26FJRWC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FJRWC worth?
The government has obligated $2,111 on SPE2DB26FJRWC.
Is contract SPE2DB26FJRWC an order under another contract?
Yes. SPE2DB26FJRWC is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWC competed?
The extent of competition for SPE2DB26FJRWC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award